Daiichi Sankyo Company, Limited (DSNKY) News
Follow Daiichi Sankyo Company, Limited (DSNKY) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Enhertu Wins EU Approval for Early Breast Cancer Treatment
Enhertu has received EU approval to treat HER2-positive early breast cancer.
REGULATION | Oct 27, 2026, 12:45 PM UTC
L
Daiichi Sankyo Co Lowers FY2026 GAAP EPS Guidance from $0.91 to $0.87 vs $1.04 Est; Raises FY2026 Sales Guidance from $14.537B to $14.684B v
Daiichi Sankyo Co (OTC: DSNKY ) lowers FY2026 GAAP EPS guidance from $0.91 to $0.87 vs $1.04 analyst estimate. Raises FY2026 sales outlook from $14.537 billion to $14.684 billion vs $13.370 billion estimate.
EARNINGS | Jul 31, 2026, 08:05 AM UTC